BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19710630)

  • 1. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy.
    Evan AP; Lingeman JE; Coe FL; Bledsoe SB; Sommer AJ; Williams JC; Krambeck AE; Worcester EM
    Kidney Int; 2009 Nov; 76(10):1081-8. PubMed ID: 19710630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease.
    Evan AP; Lingeman JE; Worcester EM; Bledsoe SB; Sommer AJ; Williams JC; Krambeck AE; Philips CL; Coe FL
    Kidney Int; 2010 Aug; 78(3):310-7. PubMed ID: 20428098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancy Between Stone and Tissue Mineral Type in Patients with Idiopathic Uric Acid Stones.
    Evan AP; Coe FL; Worcester EM; Williams JC; Heiman J; Bledsoe S; Sommer A; Philips CL; Lingeman JE
    J Endourol; 2020 Mar; 34(3):385-393. PubMed ID: 31880949
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones.
    Evan AE; Lingeman JE; Coe FL; Miller NL; Bledsoe SB; Sommer AJ; Williams JC; Shao Y; Worcester EM
    Kidney Int; 2008 Jul; 74(2):223-9. PubMed ID: 18449170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque and deposits in nine human stone diseases.
    Coe FL; Evan AP; Lingeman JE; Worcester EM
    Urol Res; 2010 Aug; 38(4):239-47. PubMed ID: 20625890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone.
    Evan AP; Lingeman JE; Coe FL; Worcester EM
    Semin Nephrol; 2008 Mar; 28(2):111-9. PubMed ID: 18359392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal histopathology of stone-forming patients with distal renal tubular acidosis.
    Evan AP; Lingeman J; Coe F; Shao Y; Miller N; Matlaga B; Phillips C; Sommer A; Worcester E
    Kidney Int; 2007 Apr; 71(8):795-801. PubMed ID: 17264873
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Borofsky MS; Handa RK; Evan AP; Williams JC; Bledsoe S; Coe FL; Worcester EM; Lingeman JE
    J Endourol; 2020 Feb; 34(2):203-208. PubMed ID: 31760802
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correspondence between stone composition and urine supersaturation in nephrolithiasis.
    Parks JH; Coward M; Coe FL
    Kidney Int; 1997 Mar; 51(3):894-900. PubMed ID: 9067927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of endoscopic lesions of the renal papilla with type of renal stone and 24 h urine analysis.
    Sabaté Arroyo XA; Grases Freixedas F; Bauzà Quetglas JL; Guimerà Garcia J; Pieras Ayala E
    BMC Urol; 2020 Apr; 20(1):46. PubMed ID: 32334600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formers.
    Viers BR; Lieske JC; Vrtiska TJ; Herrera Hernandez LP; Vaughan LE; Mehta RA; Bergstralh EJ; Rule AD; Holmes DR; Krambeck AE
    Urology; 2015 Apr; 85(4):771-6. PubMed ID: 25681832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal crystal deposits and histopathology in patients with cystine stones.
    Evan AP; Coe FL; Lingeman JE; Shao Y; Matlaga BR; Kim SC; Bledsoe SB; Sommer AJ; Grynpas M; Phillips CL; Worcester EM
    Kidney Int; 2006 Jun; 69(12):2227-35. PubMed ID: 16710357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification.
    Linnes MP; Krambeck AE; Cornell L; Williams JC; Korinek M; Bergstralh EJ; Li X; Rule AD; McCollough CM; Vrtiska TJ; Lieske JC
    Kidney Int; 2013 Oct; 84(4):818-25. PubMed ID: 23698231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of kidney stone composition in the detection of metabolic abnormalities.
    Pak CY; Poindexter JR; Adams-Huet B; Pearle MS
    Am J Med; 2003 Jul; 115(1):26-32. PubMed ID: 12867231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of renal papillae in kidney stone formers.
    Marien TP; Miller NL
    Minerva Urol Nefrol; 2016 Dec; 68(6):496-515. PubMed ID: 27441596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiopathology and etiology of stone formation in the kidney and the urinary tract.
    Evan AP
    Pediatr Nephrol; 2010 May; 25(5):831-41. PubMed ID: 19198886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology-based treatment of idiopathic calcium kidney stones.
    Coe FL; Evan A; Worcester E
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2083-92. PubMed ID: 21825103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.